Similar Posts
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
How To Create An Bioavailability Enhanced Formulation
Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
PBPK Modelling: Optimizing Controlled Release Dosage Form Development
Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…
How to Select an Optimal Formulation Strategy for Solubility
Why has solubility become a challenging aspect? The effectiveness of orally administered medicines hinges on the drug’s ability to dissolve in the gastrointestinal tract and promptly…
Translating Lab Discoveries: Preclinical to First-in-Human Development.
Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate successfully for first-in-human clinical trials. This executive summary will outline…
